S-Phase Fraction, p53, and HER-2/neu Status as Predictors of Nodal Metastasis in Early Vulvar Cancer

By Gordinier M.E.   Steinhoff M.M.   Hogan J.W.   Peipert J.F.   Gajewski W.H.   Falkenberry S.S.   Granai C.O.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 200-202

Elsevier

Access to resources Recommend Favorite

Assessment of HER2 status in breast cancer - why, when and how?

By Dowsett M.   Cooke T.   Ellis I.   Gullick W.J.   Gusterson B.   Mallon E.   Walker R.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 170-176

Elsevier

Access to resources Recommend Favorite

Effect of HER2 status on distant recurrence in early stage breast cancer

By Hess Kenneth  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 449-455

Springer Publishing Company

Access to resources Recommend Favorite

Promoter methylation status of the FHIT gene and Fhit expression: Association with HER2/neu status in breast cancer patients

By            

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2270-2278

Spandidos Publications

Access to resources Recommend Favorite

Immunohistochemical determination of her2 expression in breast cancer from core biopsy specimens: a reliable predictor of her2 status of the whole tumor

By Mueller-Holzner E.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 13-19

Springer Publishing Company

Access to resources Recommend Favorite